Dual HER2 inhibition and paclitaxel in metastatic breast cancer

被引：0
作者：
Brower, Vicki
机构：
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(14)71201-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E57 / E57
页数：1
相关论文
共 50 条
  • [41] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Amar, Surabhi
    Moreno-Aspitia, Alvaro
    Perez, Edith A.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 1 - 7
  • [42] Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
    Harbeck, Nadia
    Pegram, Mark D.
    Rueschoff, Josef
    Moebus, Volker
    BREAST CARE, 2010, 5 : 3 - 7
  • [43] HER2 as a prognostic factor in metastatic breast cancer treated with taxanes
    Parkes, E.
    McKenna, S. M.
    McAleer, J. J.
    Clarke, J.
    Clayton, A. J.
    James, C. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer
    Andre, Fabrice
    Mazouni, Chafika
    Liedtke, Cornelia
    Kau, Shu-Wan
    Frye, Debby
    Green, Marjorie
    Gonzalez-Angulo, Ana M.
    Symmans, W. Fraser
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 183 - 190
  • [45] Herceptin - For metastatic breast cancer tumors that overexpress the HER2 protein
    不详
    FORMULARY, 1998, 33 (11) : 1046 - 1047
  • [46] Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer
    Wolff, Antonio C.
    Mcshane, Lisa M.
    Allison, Kimberly H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08) : 829 - 831
  • [47] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Surabhi Amar
    Alvaro Moreno-Aspitia
    Edith A. Perez
    Breast Cancer Research and Treatment, 2008, 109 : 1 - 7
  • [48] Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
    Knudsen, Anne-Dorthe Mosgaard
    Modvig, Mikala Wej
    Vogsen, Marianne
    Kodahl, Annette Raskov
    MEDICAL ONCOLOGY, 2024, 41 (05)
  • [49] Outcome of non-metastatic HER2 positive breast cancer
    Mehmood, T.
    Rashid, A.
    Irfan, N.
    Hameed, S.
    Shah, M. Ali
    Jamshed, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S54 - S54
  • [50] Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer
    Marin, Arnaldo
    Al Mamun, Abdullah
    Patel, Hima
    Akamatsu, Hiroaki
    Ye, Dan
    Sudhan, Dhivya R.
    Eli, Lisa
    Marcelain, Katherine
    Brown, Benjamin P.
    Meiler, Jens
    Arteaga, Carlos L.
    Hanker, Ariella B.
    CANCER RESEARCH, 2023, 83 (18) : 3145 - 3158
12345